M. Blanca-tamayo

发表

Adaptation of the Categories Johns-hopkins Acg Case-mix System in Primary Healthcare: A Longitudinal, Retrospective Claim Database Study

E. Hermosilla-Pérez, R. Navarro-Artieda, B. Poblador-Plou, 2011 .

Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2008, Neuropsychiatric disease and treatment.

[Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting].

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2010 .

Clinical validity of a population database definition of remission in patients with major depression

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2010, BMC public health.

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care

J. Maurino, A. Sicras-Mainar, R. Navarro-Artieda, 2012, Annals of General Psychiatry.

Influence of the CYP2D6 Isoenzyme in Patients Treated with Venlafaxine for Major Depressive Disorder: Clinical and Economic Consequences

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2014, PloS one.

The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases

A. Sicras-Mainar, R. Navarro-Artieda, Jaume Benavent-Àreu, 2009, BMC public health.

Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2008, European Psychiatry.

[Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2009, Atencion primaria.

Influence of combinations of drugs that act on the CYP2D6 metabolic pathway in the treatment of major depressive disorder: A population-based study

A. Sicras-Mainar, R. Navarro-Artieda, M. Blanca-tamayo, 2014, European Psychiatry.

C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice

A Sicras-Mainar, J Rejas-Gutiérrez, R Navarro-Artieda, 2013, European Psychiatry.

Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences

A. Sicras-Mainar, M. Blanca-tamayo, Jordi Salvatella-Pasant, 2010, Current medical research and opinion.

Original article Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences

A. Sicras-Mainar, M. Blanca-tamayo, R. Navarro-artieda, 2010 .

Impacto de la morbilidad, uso de recursos y costes en el mantenimiento de la remisión de la depresión mayor en España: estudio longitudinal de ámbito poblacional

A. Sicras-Mainar, M. Blanca-tamayo, L. Gutiérrez-Nicuesa, 2010 .

The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases

A. Sicras-Mainar, S. Velasco-Velasco, Concepción Violán-Fors, 2009, BMC public health.

Influence of combinations of drugs that act on the CYP2D6 metabolic pathway in the treatment of major depressive disorder: A population-based study

A. Sicras-Mainar, M. Blanca-tamayo, P. Guijarro, 2014, European Psychiatry.